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The occurrence of cystic fibrosis (CF) and sarcoidosis is
not previously reported in childhood. Hypergammaglob-
inaemia and immune complex deposition may contribute
to granulomata formation in sarcoidosis.
Following diagnosis of cystic fibrosis at 3 months old and
despite standard CF management of daily nebulized colo-
mycin, cefaclor, intravenous colistin and tobramycin this
female patient became colonized with pseudomonas and
by mid childhood had impaired pulmonary function with
FEV1 67%, FVC 81% predicted. At 11 yrs, she developed
episodes of rash, joint swelling and pyrexia.
Skin biopsy: florid vasculitis affecting small and medium
sized vessels. Colchicine 500 mg tds initially helped but
aged 12 yrs, her renal function fell acutely with serum cre-
atinine 197, urea 19.3, ACR of 20, and calcium 4.3. 1,25
OH Vitamin D levels high at 120 mmol/l and angiotensin
converting enzyme (ACE) raised at 137 mmol/l.
Renal biopsy: extensive interstitial nephritis with multiple
foci of non-caseating granulomata and multinucleated
giant cells.
Renal angiography: small vessel vasculitis without micro-
aneurysms.
She had episodes of red, sore eyes.
Conjuctival biopsy: non-necrotising epithelial granu-
loma.
Sarcoidosis was diagnosed.
A high resolution CT scan of the chest showed CF changes
only.
The hypercalcaemia and ACE responded rapidly to meth-
ylprednisolone. Her lung and renal function improved on
maintenance azathioprine and prednisolone. By 6
months she was unable to wean steroids adequately with-
out flaring.
A report of mycophenolate use in a post-transplant adult
cystic fibrosis patient encouraged us to try mycophenolate
instead and she now remains in remission with improve-
ment of her cystic fibrosis lung disease as well.
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